Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Patterson

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Infectious Diseases|October 31, 2014
Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniaeRon Dagan, Christine Juergens, James Trammel, et al.
Vaccine|May 13, 2016
Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderlyCornelis H van Werkhoven, Rosalind C Hollingsworth, Susanne M Huijts, et al.
Blood Advances|June 23, 2020
Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasmsMichael A Spinner, Alexey Aleshin, Marianne T Santaguida, et al.
Journal of the Association for Research in Otolaryngology : JARO|October 21, 2024
Vital Dye Uptake of YO-PRO-1 and DASPEI Depends Upon Mechanoelectrical Transduction Function in Zebrafish Hair CellsAshley Scott Patterson, Joseph Dugdale, Alaa Koleilat, et al.
The Pediatric Infectious Disease Journal|October 11, 2011
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously immunized with 7-valent pneumococcal conjugate vaccineRobert Frenck, Allison Thompson, Sylvia H Yeh, et al.
The Pediatric Infectious Disease Journal|April 16, 2013
Immunogenicity, safety and tolerability of 3 lots of 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in the United StatesTerry Payton, Douglas Girgenti, Robert W Frenck, et al.
Administration and Policy in Mental Health|May 14, 2020
Pre-implementation Evaluation of PARTNER-MH: A Mental Healthcare Disparity Intervention for Minority Veterans in the VHAJohanne Eliacin, Marianne S Matthias, Diana J Burgess, et al.
Blood|December 24, 2005
Regulation of hematopoiesis in vitro and in vivo by invariant NKT cellsIoannis Kotsianidis, Jonathan D Silk, Emmanouil Spanoudakis, et al.
SLAS Discovery : Advancing Life Sciences R & D|December 15, 2023
Ex vivo discovery of synergistic drug combinations for hematologic malignanciesKamran A Ali, Reecha D Shah, Anukriti Dhar, et al.
Translational Behavioral Medicine|May 2, 2023
Outcomes of a peer-led navigation program, PARTNER-MH, for racially minoritized Veterans receiving mental health services: a pilot randomized controlled trial to assess feasibility and acceptabilityJohanne Eliacin, Diana Burgess, Angela L Rollins, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Infectious Diseases|October 31, 2014
Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniaeRon Dagan, Christine Juergens, James Trammel, et al.
Vaccine|May 13, 2016
Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderlyCornelis H van Werkhoven, Rosalind C Hollingsworth, Susanne M Huijts, et al.
Blood Advances|June 23, 2020
Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasmsMichael A Spinner, Alexey Aleshin, Marianne T Santaguida, et al.
Journal of the Association for Research in Otolaryngology : JARO|October 21, 2024
Vital Dye Uptake of YO-PRO-1 and DASPEI Depends Upon Mechanoelectrical Transduction Function in Zebrafish Hair CellsAshley Scott Patterson, Joseph Dugdale, Alaa Koleilat, et al.
The Pediatric Infectious Disease Journal|October 11, 2011
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously immunized with 7-valent pneumococcal conjugate vaccineRobert Frenck, Allison Thompson, Sylvia H Yeh, et al.
The Pediatric Infectious Disease Journal|April 16, 2013
Immunogenicity, safety and tolerability of 3 lots of 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in the United StatesTerry Payton, Douglas Girgenti, Robert W Frenck, et al.
Administration and Policy in Mental Health|May 14, 2020
Pre-implementation Evaluation of PARTNER-MH: A Mental Healthcare Disparity Intervention for Minority Veterans in the VHAJohanne Eliacin, Marianne S Matthias, Diana J Burgess, et al.
Blood|December 24, 2005
Regulation of hematopoiesis in vitro and in vivo by invariant NKT cellsIoannis Kotsianidis, Jonathan D Silk, Emmanouil Spanoudakis, et al.
SLAS Discovery : Advancing Life Sciences R & D|December 15, 2023
Ex vivo discovery of synergistic drug combinations for hematologic malignanciesKamran A Ali, Reecha D Shah, Anukriti Dhar, et al.
Translational Behavioral Medicine|May 2, 2023
Outcomes of a peer-led navigation program, PARTNER-MH, for racially minoritized Veterans receiving mental health services: a pilot randomized controlled trial to assess feasibility and acceptabilityJohanne Eliacin, Diana Burgess, Angela L Rollins, et al.
Pageof 7